Assessment of the properties of the EQ-5D-5L in patients with type 2 diabetes mellitus: a systematic review and meta-analysis

References

• Godman B, Haque M, Leong T, et al. The current situation regarding long-acting insulin analogues including biosimilars among African, asian, European, and south American countries; findings and implications for the future. Front Public Health. 2021;9:636.
   Web of Science ®Google Scholar
• Organisation WH. Diabetes action now: an initiative of the World Health Organization and the international diabetes federation. 2019.
   Google Scholar
• Cheloni R, Gandolfi SA, Signorelli C, et al. Global prevalence of diabetic retinopathy: protocol for a systematic review and meta-analysis. BMJ Open. 2019;9(3):e022188.
   PubMed Web of Science ®Google Scholar
• Association AD. Economic costs of diabetes in the US in 2017. Diabetes Care. 2018;41(5):917–928.
   PubMed Web of Science ®Google Scholar
• Stenman U, Hakama M, Knekt P, et al. Measurement and modeling of health-related quality of life. Epidem Demog Public Health. 2010;195(1):130–135.
   Google Scholar
• NICE U. Guide to the methods of technology appraisal. London UK: National Institute for Health and Clinical Excellence (NICE); 2008.
   Google Scholar
• Group TE. EuroQol-a new facility for the measurement of health-related quality of life. Health Policy. 1990;16(3):199–208.
   PubMed Web of Science ®Google Scholar
• Herdman M, Gudex C, Lloyd A, et al. Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L). Qual Life Res. 2011;20(10):1727–1736.
   PubMed Web of Science ®Google Scholar
• Longworth L, Yang Y, Young T, et al. Use of generic and condition-specific measures of health-related quality of life in NICE decision-making: a systematic review, statistical modelling and survey. Health Technol Assess. 2014;18(9). DOI:10.3310/hta18090.
   Web of Science ®Google Scholar
• Buchholz I, Janssen MF, Kohlmann T, et al. A systematic review of studies comparing the measurement properties of the three-level and five-level versions of the EQ-5D. Pharmacoeconomics. 2018;36(6):645–661.
   PubMed Web of Science ®Google Scholar
• Nahvijou A, Safari H, Ameri H. Comparing the performance of the EQ-5D-5L with two versions of the SF-6Dv2 in patients with breast cancer. Health Services Outcomes Res Methodol. 2020;20(2–3):183–194.
   Web of Science ®Google Scholar
• Ameri H, Safari H, Yousefi M. Interim value set for the EQ-5D-5L in Iran using the Crosswalk method. Med J Islamic Republic Iran. 2020;34:121.
   PubMedGoogle Scholar
• Janssen M, Lubetkin E, Sekhobo J, et al. The use of the EQ‐5D preference‐based health status measure in adults with type 2 diabetes mellitus. Diabetic Med. 2011;28(4):395–413.
   PubMed Web of Science ®Google Scholar
• Liberati A, Altman DG, Tetzlaff J, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. PLoS Med. 2009;6(7):e1000100.
   PubMed Web of Science ®Google Scholar
• Cronbach LJ, Meehl PE. Construct validity in psychological tests. Psychol Bull. 1955;52(4):281.
   PubMed Web of Science ®Google Scholar
• Hattie J, Cooksey RW. Procedures for assessing the validities of tests using the” known-groups” method. Appl Psychol Meas. 1984;8(3):295–305.
   Web of Science ®Google Scholar
• Terwee CB, Prinsen CA, Chiarotto A, et al. COSMIN methodology for evaluating the content validity of patient-reported outcome measures: a Delphi study. Qual Life Res. 2018;27(5):1159–1170.
   PubMed Web of Science ®Google Scholar
• Nahvijou A, Safari H, Ameri H. Psychometric properties of the SF-6Dv2 in an Iranian breast cancer population. Breast Cancer. 2021;28(1):1–7.
   PubMed Web of Science ®Google Scholar
• Nahvijou A, Safari H, Yousefi M, et al. Mapping the cancer-specific FACT-B onto the generic SF-6Dv2. Breast Cancer. 2021;28(1):130–136.
   PubMed Web of Science ®Google Scholar
• Carmines EG, Zeller RA. Reliability and validity assessment. USA: Sage publications; 1979.
   Google Scholar
• Fleiss JL, Levin B, Paik MC. Statistical methods for rates and proportions. USA: john wiley & sons; 2013.
   Google Scholar
• Rosner B. Fundamentals of biostatistics Fifth edition. USA: Duxbury Thomson learning–united state; 2000.
   Google Scholar
• Sothornwit J, Srisawasdi G, Suwannakin A, et al. Decreased health-related quality of life in patients with diabetic foot problems. Diabetes Metabolic Syndrome Obesity. 2018;11:35.
   PubMed Web of Science ®Google Scholar
• Pattanaphesaj J, Thavorncharoensap M. Measurement properties of the EQ-5D-5L compared to EQ-5D-3L in the Thai diabetes patients. Health Qual Life Outcomes. 2015;13(1):1.
   PubMed Web of Science ®Google Scholar
• Sayah FA, Qiu W, Xie F, et al. Comparative performance of the EQ-5D-5L and SF-6D index scores in adults with type 2 diabetes. Qual Life Res. 2017;26(8):2057–2066.
   PubMed Web of Science ®Google Scholar
• Koh D, Abdullah AM, Wang P, et al. Validation of Brunei’s Malay EQ-5D questionnaire in patients with type 2 diabetes. PloS One. 2016;11(11):e0165555.
   PubMed Web of Science ®Google Scholar
• Sa’ed HZ, Al-Jabi SW, Sweileh WM, et al. Relationship of treatment satisfaction to health-related quality of life among Palestinian patients with type 2 diabetes mellitus: findings from a cross-sectional study. J Clin Transl Endocrinol. 2015;2(2):66–71.
   PubMedGoogle Scholar
• Arifin B, Idrus LR, van Asselt AD, et al. Health-related quality of life in Indonesian type 2 diabetes mellitus outpatients measured with the Bahasa version of EQ-5D. Qual Life Res. 2019;28(5):1179–1190.
   PubMed Web of Science ®Google Scholar
• Abedini MR, Bijari B, Miri Z, et al. The quality of life of the patients with diabetes type 2 using EQ-5D-5 L in Birjand. Health Qual Life Outcomes. 2020;18(1):18.
   PubMed Web of Science ®Google Scholar
• Parik PC, Patel VJ. Health-related quality of life of patients with type 2 diabetes mellitus at a tertiary care hospital in India using Eq 5D 5L. Indian J Endocrinol Metab. 2019;23(4):407.
   PubMedGoogle Scholar
• Khatib ST, Hemadneh MK, Hasan SA, et al. Quality of life in hemodialysis diabetic patients: a multicenter cross-sectional study from Palestine. BMC Nephrol. 2018;19(1):1–9.
   PubMed Web of Science ®Google Scholar
• Natasya A, Andrajati R, Sauriasari R. Cross-sectional study of association between glycemic control and quality of life among diabetic patients. Int J Appl Pharm. 2018;10(1):92–96.
   PubMedGoogle Scholar
• Adibe MO, Anosike C, Nduka SO, et al. Evaluation of health status of type 2 diabetes outpatients receiving care in a tertiary hospital in Nigeria. PharmacoEconomics-open. 2018;2(3):337–345.
   PubMed Web of Science ®Google Scholar
• Arifin B, Purba FD, Herman H, et al. Comparing the EQ-5D-3 L and EQ-5D-5 L: studying measurement and scores in Indonesian type 2 diabetes mellitus patients. Health Qual Life Outcomes. 2020;18(1):1.
   PubMed Web of Science ®Google Scholar
• Kangwanrattanakul K, Gross CR, Sunantiwat M, et al. Adding two culture-specific ‘bolt-on’dimensions on the Thai version of EQ-5D-5L: an exploratory study in patients with diabetes. Expert Rev Pharmacoecon Outcomes Res. 2019;19(3):321–329.
   PubMed Web of Science ®Google Scholar
• Janssen MF, Pickard AS, Golicki D, et al. Measurement properties of the EQ-5D-5L compared to the EQ-5D-3L across eight patient groups: a multi-country study. Qual Life Res. 2013;22(7):1717–1727.
   PubMed Web of Science ®Google Scholar
• Pan CW, Sun HP, Wang X, et al. The EQ-5D-5L index score is more discriminative than the EQ-5D-3L index score in diabetes patients. Qual Life Res. 2015;24(7):1767–1774.
   PubMed Web of Science ®Google Scholar
• Wang Y, Tan NC, Tay EG, et al. Cross-cultural measurement equivalence of the 5-level EQ-5D (EQ-5D-5L) in patients with type 2 diabetes mellitus in Singapore. Health Qual Life Outcomes. 2015;13(1):1.
   PubMed Web of Science ®Google Scholar
• Bilbao A, García-Pérez L, Arenaza JC, et al. Psychometric properties of the EQ-5D-5L in patients with hip or knee osteoarthritis: reliability, validity and responsiveness. Qual Life Res. 2018;27(11):2897–2908.
   PubMed Web of Science ®Google Scholar
• Pan C-W, Sun H-P, Zhou H-J, et al. Valuing health-related quality of life in type 2 diabetes patients in China. Med Decis Mak. 2016;36(2):234–241.
   PubMed Web of Science ®Google Scholar
• Wang P, Luo N, Tai ES, et al. The EQ-5D-5L is More Discriminative Than the EQ-5D-3L in patients with diabetes in Singapore. Value in Health Regional Issues. 2016;9:57–62.
   PubMedGoogle Scholar
• Yfantopoulos J, Chantzaras A. Health-related quality of life and health utilities in insulin-treated type 2 diabetes: the impact of related comorbidities/complications. Eur J Health Econ. 2020;21(5) ;729–743.
   PubMed Web of Science ®Google Scholar
• Zare F, Ameri H, Madadizadeh F, et al. Health-related quality of life and its associated factors in patients with type 2 diabetes mellitus. SAGE Open Medicine. 2020;8:2050312120965314.
   Web of Science ®Google Scholar
• Golicki D, Niewada M, van Hout B, et al. Interim EQ-5D-5L value set for Poland: first crosswalk value set in central and eastern europe. Value in Health Regional Issues. 2014;4:19–23.
   PubMedGoogle Scholar
• Golicki D, Niewada M, Buczek J, et al. Validity of EQ-5D-5L in stroke. Qual Life Res. 2015;24(4):845–850.
   PubMed Web of Science ®Google Scholar
• Kim SH, Kim HJ, Lee S-i JM-W. Comparing the Psychometric Properties of the EQ-5D-3L and EQ-5D-5L in Cancer Patients in Korea. Qual Life Res. 2012;21(6):1065–1073.
   PubMed Web of Science ®Google Scholar
• Rencz F, Lakatos PL, Gulácsi L, et al. Validity of the EQ-5D-5L and EQ-5D-3L in patients with Crohn’s disease. Qual Life Res. 2019;28(1):141–152.
   PubMed Web of Science ®Google Scholar
• Kim TH, Jo M-W, Lee S-I, et al. Psychometric Properties of the EQ-5D-5L in the General Population of South Korea. Qual Life Res. 2013;22(8):2245–2253.
   PubMed Web of Science ®Google Scholar